Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Basic and Translational - Technical Advances & Quantification (this would include image-guided diagnostics/therapy)

Can single time point dosimetry be utilized to estimate the absorbed dose with acceptable accuracy in non-Hodgkins’ lymphoma patients treated with radioimmunotherapy? Data from 2 institutes

Johan Blakkisrud, Caroline Stokke, Ayca Løndalen, Mark Kaminski and Yuni Dewaraja
Journal of Nuclear Medicine June 2023, 64 (supplement 1) P654;
Johan Blakkisrud
1University of Michigan & Oslo University Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caroline Stokke
2Oslo University Hospital & University of Oslo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ayca Løndalen
3Oslo University Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Kaminski
4University of Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuni Dewaraja
4University of Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 64 no. supplement 1 P654

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online August 28, 2023.

Copyright & Usage 
© 2023

Author Information

  1. Johan Blakkisrud1,
  2. Caroline Stokke2,
  3. Ayca Løndalen3,
  4. Mark Kaminski4 and
  5. Yuni Dewaraja4
  1. 1University of Michigan & Oslo University Hospital
  2. 2Oslo University Hospital & University of Oslo
  3. 3Oslo University Hospital
  4. 4University of Michigan

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: August 2023 to April 2025

AbstractFullPdf
Aug 2023300
Sep 20231400
Oct 2023700
Nov 20232400
Dec 20231700
Jan 20242300
Feb 2024400
Mar 2024700
Apr 20244700
May 20241300
Jun 20243600
Jul 20249800
Aug 20247800
Sep 2024600
Oct 20241200
Nov 20243400
Dec 2024800
Jan 2025900
Feb 20251200
Mar 20251100
Apr 20251300
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 64, Issue supplement 1
June 1, 2023
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Can single time point dosimetry be utilized to estimate the absorbed dose with acceptable accuracy in non-Hodgkins’ lymphoma patients treated with radioimmunotherapy? Data from 2 institutes
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Can single time point dosimetry be utilized to estimate the absorbed dose with acceptable accuracy in non-Hodgkins’ lymphoma patients treated with radioimmunotherapy? Data from 2 institutes
Johan Blakkisrud, Caroline Stokke, Ayca Løndalen, Mark Kaminski, Yuni Dewaraja
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P654;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Can single time point dosimetry be utilized to estimate the absorbed dose with acceptable accuracy in non-Hodgkins’ lymphoma patients treated with radioimmunotherapy? Data from 2 institutes
Johan Blakkisrud, Caroline Stokke, Ayca Løndalen, Mark Kaminski, Yuni Dewaraja
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P654;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • 68Ga-pentixather PET/CT for newly diagnosed multiple myeloma: Comparison to 68Ga-pentixafor PET/CT
  • Predicting Tumor Response to Neoadjuvant Chemotherapy based on Pretreatment 18F-FDG PET/CT and Clinical Parameters in Locally Advanced Oral Squamous Cell Carcinoma
  • Trial in Progress: Phase 1B Study of Personalized Ultrahypofractionated Stereotactic Ablative Radiotherapy of High-Risk Prostate Cancer Guided by PET PSMA (Gallium 68 gozetotide PSMA-11) response [PULSAR ProPhet]
Show more Oncology, Basic and Translational - Technical Advances & Quantification (this would include image-guided diagnostics/therapy)

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire